The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman.
作者信息
Lewis James H, Seeff Leonard B
机构信息
Department of Medicine Georgetown University School of Medicine Washington DC.
Department of Hepatology, Division of Gastroenterology Georgetown University Hospital Washington DC.
出版信息
Clin Liver Dis (Hoboken). 2020 Mar 2;15(Suppl 1):S25-S36. doi: 10.1002/cld.856. eCollection 2020 Feb.
Abstract
摘要
相似文献
1
The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman.
Clin Liver Dis (Hoboken). 2020 Mar 2;15(Suppl 1):S25-S36. doi: 10.1002/cld.856. eCollection 2020 Feb.
2
The American Association for the Study of Liver Diseases. Presentation of the Distinguished Achievement Award to Hyman J. Zimmerman, M.D.
Hepatology. 1987 Mar-Apr;7(2):213-5. doi: 10.1002/hep.1840070202.
3
Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges.
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S9-17. doi: 10.1007/s40264-014-0182-7.
4
Libbie Henrietta Hyman (1888-1969): from developmental mechanics to the evolution of animal body plans.
J Exp Zool B Mol Dev Evol. 2004 Sep 15;302(5):413-23. doi: 10.1002/jez.b.21019.
5
The roles of stimulus and response uncertainty in forced-choice performance: an amendment to Hick/Hyman Law.
Psychol Res. 2016 Jul;80(4):555-65. doi: 10.1007/s00426-015-0675-8. Epub 2015 Jun 10.
6
Phylogeny and taxonomic revision of Deronectina Galewski, 1994 (Coleoptera: Dytiscidae: Hydroporinae: Hydroporini).
Zootaxa. 2018 Sep 12;4474(1):1-104. doi: 10.11646/zootaxa.4474.1.1.
7
Individual differences in the impact of vicarious racism: African American students react to the George Zimmerman trial.
Cultur Divers Ethnic Minor Psychol. 2017 Apr;23(2):174-184. doi: 10.1037/cdp0000099. Epub 2016 Oct 13.
8
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.
Front Pharmacol. 2015 Apr 23;6:72. doi: 10.3389/fphar.2015.00072. eCollection 2015.
9
Hyman J. Weiner's use of systems and population approaches: their relevance to social work practice in health care today.
Soc Work Health Care. 1983 Winter;9(2):5-14. doi: 10.1300/j010v09n02_03.
10
Effects of average uncertainty and trial-type frequency on choice response time: A hierarchical extension of Hick/Hyman Law.
Psychon Bull Rev. 2017 Dec;24(6):2012-2020. doi: 10.3758/s13423-017-1263-2.
引用本文的文献
1
Prevalence of Polypharmacy Among Patients with Chronic Liver Disease-A Narrative Literature Review.
J Clin Med. 2025 Sep 5;14(17):6263. doi: 10.3390/jcm14176263.
本文引用的文献
1
Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Drug Saf. 2018 Aug;41(8):735-743. doi: 10.1007/s40264-018-0654-2.
2
The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.
Clin Gastroenterol Hepatol. 2015 Nov;13(12):2173-89.e8. doi: 10.1016/j.cgh.2015.06.017. Epub 2015 Jun 23.
3
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6.
4
LiverTox: a website on drug-induced liver injury.
Hepatology. 2013 Mar;57(3):873-4. doi: 10.1002/hep.26175.
5
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
Hepatology. 2010 Jun;51(6):2117-26. doi: 10.1002/hep.23577.
6
Infectious hepatitis; clinical and laboratory features of 295 cases.
Am J Med Sci. 1947 Apr;213(4):395-409. doi: 10.1097/00000441-194704000-00002.
7
Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.
Clin Liver Dis. 2007 Aug;11(3):477-505, v. doi: 10.1016/j.cld.2007.06.003.
8
How can 'Hy's law' help the clinician?
Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):235-9. doi: 10.1002/pds.1210.
9
Hy's law: predicting serious hepatotoxicity.
Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):241-3. doi: 10.1002/pds.1211.
10
'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.
Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):221-9. doi: 10.1002/pds.1209.
Zotero 插件